Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie R Land

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 2, 2007
What do patients want from their radiation oncologist? Initial results from a prospective trialAjay K Bhatnagar, Stephanie R Land, Alyson Shogan, et al.
Carcinogenesis|March 4, 2006
Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancerLaura P Stabile, Jennifer S Lyker, Stephanie R Land, et al.
Journal of the National Cancer Institute|November 29, 2015
Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1Stephanie R Land, Farzana L Walcott, Qing Liu, et al.
Breast Cancer Research and Treatment|September 14, 2007
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife womenDavid Cella, Stephanie R Land, Chih-Hung Chang, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2008
Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanomaWenjun Wang, Howard D Edington, Drazen M Jukic, et al.
Carcinogenesis|August 4, 2012
Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogensLaura P Stabile, Mary E Rothstein, Diana E Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Funding patient-reported outcomes in cancer clinical trialsCarol M Moinpour, Andrea M Denicoff, Deborah Watkins Bruner, et al.
Drug and Alcohol Dependence|March 2, 2021
Smoking and cessation behaviors in patients at federally funded health centers - United States, 2014Erika S Trapl, Brenna VanFrank, Christine M Kava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2bWenjun Wang, Howard D Edington, Uma N M Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responsesStergios J Moschos, Howard D Edington, Stephanie R Land, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|October 2, 2007
What do patients want from their radiation oncologist? Initial results from a prospective trialAjay K Bhatnagar, Stephanie R Land, Alyson Shogan, et al.
Carcinogenesis|March 4, 2006
Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancerLaura P Stabile, Jennifer S Lyker, Stephanie R Land, et al.
Journal of the National Cancer Institute|November 29, 2015
Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1Stephanie R Land, Farzana L Walcott, Qing Liu, et al.
Breast Cancer Research and Treatment|September 14, 2007
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife womenDavid Cella, Stephanie R Land, Chih-Hung Chang, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2008
Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanomaWenjun Wang, Howard D Edington, Drazen M Jukic, et al.
Carcinogenesis|August 4, 2012
Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogensLaura P Stabile, Mary E Rothstein, Diana E Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Funding patient-reported outcomes in cancer clinical trialsCarol M Moinpour, Andrea M Denicoff, Deborah Watkins Bruner, et al.
Drug and Alcohol Dependence|March 2, 2021
Smoking and cessation behaviors in patients at federally funded health centers - United States, 2014Erika S Trapl, Brenna VanFrank, Christine M Kava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2bWenjun Wang, Howard D Edington, Uma N M Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responsesStergios J Moschos, Howard D Edington, Stephanie R Land, et al.
Pageof 10